Vera Therapeutics Inc (VERA)
49.00
-0.43
(-0.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.99
+0.99
(+2.02%)
Pre-Market: 08:07
Vera Therapeutics Shareholders Equity (Quarterly): 289.06M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 289.06M |
| June 30, 2024 | 327.87M |
| March 31, 2024 | 353.54M |
| December 31, 2023 | 101.68M |
| September 30, 2023 | 123.71M |
| June 30, 2023 | 140.52M |
| March 31, 2023 | 157.71M |
| December 31, 2022 | 76.91M |
| Date | Value |
|---|---|
| September 30, 2022 | 105.72M |
| June 30, 2022 | 121.50M |
| March 31, 2022 | 134.42M |
| December 31, 2021 | 69.59M |
| September 30, 2021 | 85.48M |
| June 30, 2021 | 92.16M |
| March 31, 2021 | -93.32M |
| December 31, 2020 | -89.35M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-93.32M
Minimum
Mar 2021
353.54M
Maximum
Mar 2024
124.83M
Average
113.61M
Median
Shareholders Equity (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp | 241.22M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.56M |
| Total Liabilities (Quarterly) | 79.50M |